-
2023-507482-26-00
5
2024-10-04
Castrate-resistant prostate cancer with oligometastases on functional
-
2023-508338-33-00
5
2024-10-01
Chronic Inflammatory Demyelinating Polyneuropathy
-
2022-502408-57-00
5
2024-09-04
Novo metastatic hormone-sensitive prostate cancer (mHSPC) patients hav
-
2024-510917-14-00
5
2024-09-03
Angelman Syndrome
-
2023-506503-26-00
5
2024-07-31
Polyneuropathy, Inflammatory Demyelinating, Chronic
-
2023-507684-19-00
5
2024-07-24
FGFR+ Intermediate-risk Non-muscle Invasive Bladder Cancer
-
2023-510536-37-00
4
2024-07-05
Prostate Cancer
-
2023-508442-18-00
5
2024-04-14
Patients with an infection of the osteosynthesis material implanted af
-
2023-503208-94-00
6
2024-04-04
Prostate cancer
-
2023-504031-41-00
5
2024-03-25
ER+/HER2- Early Breast Cancer
-
2023-504323-25-01
5
2024-03-19
breast cancer
-
2023-505141-48-00
5
2024-03-07
Fibrosis
-
2023-504735-41-00
5
2024-03-05
Moderately to Severely Active Crohn's Disease
-
2023-505251-43-00
5
2024-02-28
Primary Biliary Cholangitis
-
2022-502113-28-00
5
2024-02-01
Follicular lymphoma
-
2023-509142-35-00
6
2024-01-29
Atrial fibrillation after stress (e.g., noncardiac surgery or acute me
-
2022-502413-29-00
4
2024-01-22
BRAF V600E mutated and microsatellite stable (MSS) advanced colorectal
-
2022-502984-39-00
5
2023-12-13
Severe Uncontrolled Asthma
Asthma (an illness that causes breathing di
-
2023-503224-66-00
5
2023-10-31
Atrial Fibrillation
-
2022-501899-26-00
5
2023-09-01
Asthma
-
2024-513102-57-00
5
2023-07-05
infertility
-
2024-518677-34-00
6
2023-03-15
Emergency cholecystectomy is the gold standard treatment for acute cho
-
2023-506239-14-00
5
2022-12-13
Crohn’s Disease
-
2024-512382-13-00
5
2022-10-04
Migraine (with or without aura)